Predicting antigenic peptides suitable for the selection of phage antibodies

Human Antibodies

Volumn 12, Issue 4, 2003, Pages 99-112

  Pavlik, Peter ^a   Siegel, Robert W ^a,b   Marzari, Roberto ^c   Sblattero, Daniele ^c   Verzillo, Vittorio ^a   Collins, Colin ^d   Marks, James D ^d   Bradbury, Andrew ^a,e  

^a LOS ALAMOS NATIONAL LABORATORY   (United States)

^b PACIFIC NORTHWEST NATIONAL LABORATORY   (United States)

^c UNIVERSITY OF TRIESTE   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e SISSA   (Italy)

Author keywords

High throughput selection; Peptides; Phage display; Single chain antibodies

Indexed keywords

BACTERIUM ANTIBODY; POLYCLONAL ANTIBODY; PROTEIN; PROTEIN P53; PROTEIN ZNF217; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; UNCLASSIFIED DRUG;

ALGORITHM; ANTIBODY LIBRARY; ANTIBODY SCREENING; ANTIGENICITY; ARTICLE; BINDING SITE; ENZYME LINKED IMMUNOSORBENT ASSAY; HIGH THROUGHPUT SCREENING; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; WESTERN BLOTTING;

EID: 2442660157     PISSN: 10932607     EISSN: None     Source Type: Journal    
DOI: 10.3233/hab-2003-12401     Document Type: Article

References (56)

1. G. Winter, A.D. Griffiths, R.E. Hawkins and H.R. Hoogenboom, Making antibodies by phage display technology, Annu Rev Immunol 12 (1994), 433-455.
2. A.D. Griffiths, S.C. Williams, O. Hartley, I.M. Tomlinson, P. Waterhouse, W.L. Crosby, R.E. Kontermann, P.T. Jones, N.M. Low, T.J. Alison, T.D. Prospero, H.R. Hoogenboom, A. Nissim, J.P.L. Cox, J.L. Harrison, M. Zaccolo, E. Gherardi and G. Winter, Isolation of high affinity human antibodies directly from large synthetic repertoires, EMBO J 13 (1994), 3245-3260.
3. A. Knappik, L. Ge, A. Honegger, P. Pack, M. Fischer, G. Wellnhofer, A. Hoess, J. Wolle, A. Pluckthun and B. Virnekas, Fully Synthetic Human Combinatorial Antibody Libraries (HuCAL) Based on Modular Consensus Frameworks and CDRs Randomized with Trinucleotides, J Mol Biol 296 (2000), 57-86.
4. E. Soderlind, M. Vergeles and C.A. Borrebaeck, Domain libraries: synthetic diversity for de novo design of antibody V-regions, Gene 160 (1995), 269-272.
5. D. Sblattero and A. Bradbury, Exploiting recombination in single bacteria to make large phage antibody libraries, Nat. Biotech. 18 (2000), 75-80.
6. M.D. Sheets, P. Amersdorfer, R. Finnern, P. Sargent, E. Lindqvist, R. Schier, G. Hemmingsen, C. Wong, J.C. Gerhart and J.D. Marks, Efficient construction of a large nonimmune phage antibody library; the production of panels of high affinity human single-chain antibodies to protein antigens, Proc Natl Acad Sci USA 95 (1998), 6157-6162.
7. H.J. de Haard, N. van Neer, A. Reurs, S.E. Hufton, R.C. Roovers, P. Henderikx, A.P. de Bruine, J.W. Arends and H.R. Hoogenboom, A large non-immunized human Fab fragment phage library that permits rapid isolation and kinetic analysis of high affinity antibodies, J Biol Chem 274 (1999), 18218-18230.
8. J.D. Marks, H.R. Hoogenboom, T.P. Bonnert, J. McCafferty, A.D. Griffiths and G. Winter, By-passing immunization. Human antibodies from V-gene libraries displayed on phage, J. Mol. Biol. 222 (1991), 581-597.
9. J.K. Percus, O.E. Percus and A.S. Perelson, Predicting the size of the T-cell receptor and antibody combining region from consideration of efficient self-nonself discrimination, Proc Natl Acad Sci 90 (1993), 1691-1695.
10. D.R. Davies and G.H. Cohen, Interactions of protein antigens with antibodies, Proc Natl Acad Sci 93 (1996), 7-12.
11. B.A. Fields, F.A. Goldbaum, W. Dall'Acqua, E.L. Malchiodi, A. Cauerhff, F.P. Schwarz, X. Ysern, R.J. Poljak and R.A. Mariuzza, Hydrogen bonding and solvent structure in an antigen-antibody interface. Crystal structures and thermodynamic characterization of three Fv mutants complexed with lysozyme, Biochemistry 35 (1996), 15494-15503.
12. J.E. Coligan, J.P. Tam and J. Shao, Production of Antipeptide Antisera, in: Current Protocols in Neuroscience, G.P. Crooks, ed., John Wiley & Sons, Inc., 1997, pp. 5.6.1-5.6.21.
13. M. Van Regenmortel, J. Briand, S. Muller and S. Plaué, Synthetic polypeptides as antigens, in: Laboratory techniques in biochemistry and molecular biology, P. van Knippenberg, ed., Elsevier, Amsterdam, 1988.
14. M.H. Van Regenmortel and J.L. Pellequer, Predicting antigenic determinants in proteins: looking for unidimensional solutions to a three-dimensional problem? Pept Res 7 (1994), 224-228.
15. H.M. Cooper, P.E. Todd and S.J. Leach, Antibody response to the C-terminal peptide sequence in beef myoglobin, Mol Immunol 23 (1986), 1289-1299.
16. F. Zavala, J.P. Tam, P.J. Barr, P.J. Romero, V. Ley, R.S. Nussenzweig and V. Nussenzweig, Synthetic peptide vaccine confers protection against murine malaria, J Exp Med 166 (1987), 1591-1596.
17. I. Harari, A. Donohue-Rolfe, G. Keusch and R. Arnon, Synthetic peptides of Shiga toxin B subunit induce antibodies which neutralize its biological activity, Infect Immun 56 (1988), 1618-1624.
18. P. Askelof, K. Rodmalm, G. Wrangsell, U. Larsson, S.B. Svenson, J.L. Cowell, A. Unden and T. Bartfai, Protective immunogenicity of two synthetic peptides selected from the amino acid sequence of Bordetella pertussis toxin subunit S1, Proc Natl Acad Sci USA 87 (1990), 1347-1351.
19. A.M. Kleine, J.F. Glatz, F.A. van Nieuwenhoven, M.I. Vallinga, M.H. Salden, F.T. Bosman, W.J. Borsma, N.D. Zegers and G.J. van der Vusse, Type-specific immunodetection of human heart fatty acid-binding protein with polyclonal anti-peptide antibodies, Mol Cell Biochem 98 (1990), 41-48.
20. C.R. Young and M.Z. Atassi, Antibodies to sperm-whale myoglobin evoked by free synthetic peptides of an antigenic site, Immunological Communications 11 (1982), 9-16.
21. H.M. Geysen, J.A. Tainer, S.J. Rodda, T.J. Mason, H. Alexander, E.D. Getzoff and R.A. Lerner, Chemistry of antibody binding to a protein, Science 235 (1987), 1184-1190.
22. F.A. Anderer and H.D. Schlumberger, [Cross reactions of antiserums against heterologous terminal amino acid sequences and two strains of the tobacco mosaic virus], Z Naturforsch B20 (1965), 564-568.
23. F.A. Anderer and H.D. Schlumberger, Cross-reactions of anti-sera against the terminal amino acid and dipeptide of tobacco mosaic virus, Biochim Biophys Acta 115 (1966), 222-224.
24. L. Craig, P.C. Sanschagrin, A. Rozek, S. Lackie, L.A. Kuhn and J.K. Scott, The role of structure in antibody cross-reactivity between peptides and folded proteins, Journal of Molecular Biology 281 (1998), 183-201.
25. M.Z. Atassi and A.F.S.A. Habeeb, in: Immunochemistry of Proteins, M.Z. Atassi, ed., Plenum, New York, 1977, pp. 177-264.
26. M.Z. Atassi and J. Kurisaki, A novel approach for localization of the continuous protein antigenic sites by comprehensive synthetic surface scanning: antibody and T-cell activity to several influenza hemagglutinin synthetic sites, Immunol Commun 13 (1984), 539-551.
27. M. Ferguson, S.E. Reed and P.D. Minor, Reactivity of anti-peptide and anti-poliovirus type 3 monoclonal antibodies with synthetic peptides, J Gen Virol 67(11) (1986), 2527-2531.
28. J. Kyte and R.F. Doolittle, A simple method for displaying the hydropathic character of a protein, J Mol Biol 157 (1982), 105-132.
29. P. Karplus and G. Shulz, Prediction of chain flexibility in proteins: a tool for the selection of peptide antigens, Naturwissenschaften 72 (1985), 212-213.
30. P.Y. Chou and G.D. Fasman, Prediction of the secondary structure of proteins from their amino acid sequence, Advances in Enzymology and Related Areas of Molecular Biology 47 (1978), 45-148.
31. E.A. Emini, J.V. Hughes, D.S. Perlow and J. Boger, Induction of hepatitis A virus-neutralizing antibody by a virus-specific synthetic peptide, Journal of Virology 55 (1985), 836-839.
32. B.A. Jameson and H. Wolf, The antigenic index: a novel algorithm for predicting antigenic determinants, Comput Appl Biosci 4 (1988), 181-186.
33. J. Moult, Predicting protein three-dimensional structure, Curr Opin Biotechnol 10 (1999), 583-588.
34. B. Rost, PHD: predicting one-dimensional protein structure by profile-based neural networks, Methods Enzymol 266 (1996), 525-539.
35. A.D. Griffiths, M. Malmqvist, J.D. Marks, J.M. Bye, M.J. Embleton, J. McCafferty, M. Baier, K.P. Holliger, B.D. Gorick, N.C. Hughes-Jones, H.R. Hoogenboom and G. Winter, Human anti-self antibodies with high specificity from phage display libraries, EMBO. J. 12 (1993), 725-734.
36. P. Henderikx, M. Kandilogiannaki, C. Petrarca, S. von Mensdorff-Pouilly, J.H. Hilgers, E. Krambovitis, J.W. Arends and H.R. Hoogenboom, Human single-chain Fv antibodies to MUC1 core peptide selected from phage display libraries recognize unique epitopes and predominantly bind adenocarcinoma, Cancer Res 58 (1998), 4324-4332.
37. L. Persic, I.R. Horn, S. Rybak, A. Cattaneo, H.R. Hoogenboom and A. Bradbury, Single-chain variable fragments selected on the 57-76 p21Ras neutralising epitope from phage antibody libraries recognise the native protein, FEBS lett 443 (1999), 112-116.
38. R.W. Siegel, B. Allen, P. Pavlik, J.D. Marks and A. Bradbury, Mass spectral analysis of a protein complex using single-chain antibodies selected on a peptide target: applications to functional genomics, J Mol Biol 302 (2000), 285-293.
39. W.D. Funk, D.T. Pak, R.H. Karas, W.E. Wright and J.W. Shay, A transcriptionally active DNA-binding site for human p53 protein complexes, Mol Cell Biol 12 (1992), 2866-2871.
40. Y. Sanchez, C. Wong, R.S. Thoma, R. Richman, Z. Wu, H. Piwnica-Worms and S.J. Elledge, Conservation of the Chk1 checkpoint pathway in mammals: linkage of DNA damage to Cdk regulation through Cdc25, Science 277 (1997), 1497-1501.
41. R. Marzari, D. Sblattero, F. Florian, E. Tongiorgi, T. Not, A. Tommasini, A. Ventura and A. Bradbury, Molecular dissection of the tissue transglutaminase autoantibody response in celiac disease, J Immunol 166 (2001), 4170-4176.
42. G. Melino, E. Candi and P.M. Steinert, Assays for transglutaminases in cell death, Methods Enzymol 322 (2000), 433-472.
43. N. Cirino, D. Sblattero, D. Allen, S. Peterson, J. Marks, P. Jackson, A. Bradbury and B. Lehnert, Disruption of anthrax toxin binding with the use of human antibodies and competitive inhibitors, Infection and Immunity 67 (1999), 2957-2963.
44. P. Chen, C. Luo, Y. Deng, K. Ryan, J. Register, S. Margosiak, A. Tempczyk-Russell, B. Nguyen, P. Myers, K. Lundgren, C.C. Kan and P.M. O'Connor, The 1.7 A crystal structure of human cell cycle checkpoint kinase Chk1: implications for Chk1 regulation, Cell 100 (2000), 681-692.
45. S. Liu, R.A. Cerione and J. Clardy, Structural basis for the guanine nucleotide-binding activity of tissue transglutaminase and its regulation of transamidation activity, Proc Natl Acad Sci USA 99 (2002), 2743-2747.
46. S. Vijay-Kumar, C.E. Bugg, K.D. Wilkinson and W.J. Cook, Three-dimensional structure of ubiquitin at 2.8 A resolution, Proc Natl Acad Sci USA 82 (1985), 3582-3585.
47. P.Y. Chou and G.D. Fasman, Empirical predictions of protein conformation, Annual Review of Biochemistry 47 (1978), 251-276.
48. B. Rost and C. Sander, Conservation and prediction of solvent accessibility in protein families, Proteins 20 (1994), 216-226.
49. B. Vojtesek, J. Bartek, C.A. Midgley and D.P. Lane, An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53, J Immunol Methods 151 (1992), 237-244.
50. C. Collins, J.M. Rommens, D. Kowbel, T. Godfrey, M. Tanner, S.I. Hwang, D. Polikoff, G. Nonet, J. Cochran, K. Myambo, K.E. Jay, J. Froula, T. Cloutier, W.L. Kuo, P. Yaswen, S. Dairkee, J. Giovanola, G.B. Hutchinson, J. Isola, O.P. Kallioniemi, M. Palazzolo, C. Martin, C. Ericsson, D. Pinkel and J.W. Gray et al., Positional cloning of ZNF217 and NABC1: genes amplified at 20q13.2 and overexpressed in breast carcinoma, Proc Natl Acad Sci USA 95 (1998), 8703-8708.
51. G.H. Nonet, M.R. Stampfer, K. Chin, J.W. Gray, C.C. Collins and P. Yaswen, The ZNF217 gene amplified in breast cancers promotes immortalization of human mammary epithelial cells, Cancer Res 61 (2001), 1250-1254.
52. C. Collins, S. Volik, D. Kowbel, D. Ginzinger, B. Ylstra, T. Cloutier, T. Hawkins, P. Predki, C. Martin, M. Wernick, W.L. Kuo, A. Alberts and J.W. Gray, Comprehensive genome sequence analysis of a breast cancer amplicon, Genome Res 11 (2001), 1034-1042.
53. R.M. de Wildt, C.R. Mundy, B.D. Gorick and I.M. Tomlinson, Antibody arrays for high-throughput screening of antibody-antigen interactions, Nat Biotechnol 18 (2000), 989-994.
54. H.M. Geysen, S.J. Rodda, T.J. Mason, G. Tribbick and P.G. Schoofs, Strategies for epitope analysis using peptide synthesis, J Immunol Methods 102 (1987), 259-274.
55. J.R. Van Beijnum, P.T. Moerkerk, A.J. Gerbers, A.P. De Bruine, J.W. Arends, H.R. Hoogenboom and S.E. Hufton, Target validation for genomics using peptide-specific phage antibodies: a study of five gene products overexpressed in colorectal cancer. PG, Int J Cancer 101 (2002), 118-127.
56. N. Guex and M. Peitsch, SWISS-MODEL and the Swiss-PdbViewer: An environment for comparative protein modeling, Electrophoresis 18 (1997), 2714-2723.